Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
Archive ouverte
Garassino, Marina, Chiara | Cho, Byoung-Chul | Kim, Joo-Hang | Mazières, Julien | Vansteenkiste, Johan | Lena, Hervé | Corral Jaime, Jesus | Gray, Jhanelle, E | Powderly, John | Chouaid, Christos | Bidoli, Paolo | Wheatley-Price, Paul | Park, Keunchil | Soo, Ross, A | Huang, Yifan | Wadsworth, Catherine | Dennis, Phillip, A | Rizvi, Naiyer, A | Paz-Ares Rodriguez, Luis | Novello, Silvia | Hiret, Sandrine | Schmid, Peter | Laack, Eckart | Califano, Raffaele | Maemondo, Makoto | Kim, Sang-We | Chaft, Jamie | Vicente Baz, David | Berghmans, Thierry | Kim, Dong-Wan | Surmont, Veerle | Reck, Martin | Han, Ji-Youn | Holgado Martin, Esther | Belda Iniesta, Cristobal | Oe, Yuichiro | Chella, Antonio | Chopra, Akhil | Robinet, Gilles | Soto Parra, Hector | Thomas, Michael | Cheema, Parneet | Katakami, Nobuyuki | Su, Wu-Chou | Kim, Young-Chul | Wolf, Juergen | Lee, Jong-Seok | Saka, Hideo | Milella, Michele | Ramos Garcia, Inmaculada | Sibille, Anne | Yokoi, Takashi | Kang, Eun, Joo | Atagi, Shinji | Spaeth-Schwalbe, Ernst | Nishio, Makoto | Imamura, Fumio | Gabrail, Nashat | Veillon, Remi | Derijcke, Sofie | Maeda, Tadashi | Zylla, Dylan | Kubiak, Kendra | Santoro, Armando | Uy, Ma, Noemi | Lucien Geater, Sarayut | Italiano, Antoine | Kowalski, Dariusz | Barlesi, Fabrice | Chen, Yuh-Min | Spigel, David | Chewaskulyong, Busyamas | Garcia Gomez, Ramon | Alvarez Alvarez, Rosa | Yang, Chih-Hsin | Hsia, Te-Chun | Denis, Fabrice | Sakai, Hiroshi | Vincent, Mark | Goto, Koichi | Bosch-Barrera, Joaquim | Weiss, Glen | Canon, Jean-Luc | Scholz, Christian | Aglietta, Massimo | Kemmotsu, Hirotsugu | Azuma, Koichi | Bradbury, Penelope | Feld, Ronald | Chachoua, Abraham | Jassem, Jacek | Juergens, Rosalyn | Palmero Sanchez, Ramon | Malcolm, Albert | Vrindavanam, Nandagopal | Kubota, Kaoru | Waller, Cornelius | Waterhouse, David | Coudert, Bruno | Mark, Zsuzsanna | Satouchi, Miyako | Chang, Gee-Chen | Herzmann, Christian | Chaudhry, Arvind | Giridharan, Selvaraj | Hesketh, Paul | Ikeda, Norihiko | Boccia, Ralph | Iannotti, Nichola | Haigentz, Missak | Reynolds, John | Querol, John | Nakagawa, Kazuhiko | Sugawara, Shunichi | Tan, Eng, Huat | Hirashima, Tomonori | Gettinger, Scott | Kato, Terufumi | Takeda, Koji | Juan Vidal, Oscar | Mohn-Staudner, Andrea | Panwalkar, Amit | Daniel, Davey | Kobayashi, Kunihiko | Ladrera, Guia, Elena Imelda | Schulte, Clemens | Sebastian, Martin | Cernovska, Marketa | Coupkova, Helena | Havel, Libor | Pauk, Norbert | Singh, Joginder | Murakami, Shuji | Csoszi, Tibor | Losonczy, Gyorgy | Price, Allan | Anderson, Ian | Iqbal, Mussawar | Torri, Vamsee | Juhasz, Erzsebet | Khanani, Saleem | Koubkova, Leona | Levy, Benjamin | Page, Ray | Bocskei, Csaba | Crinò, Lucio | Einspahr, David | Hagenstad, Christopher | Juat, Necy | Overton, Lindsay | Garrison, Mitchell | Szalai, Zsuzsanna
Edité par
CCSD ; Elsevier -
International audience.
has a patent T-cell immunotherapy development pending; is a founder and owner of BioCytics, which is a clinical research laboratory developing T-cell immunotherapy; and has previously bought stock in the T-cell companies LionBiotech, Juno, Blue Bird, Kite Pharma, and ZioPharm. CC has received fees during the past 5 years for attending scientific meetings, speaking, organising research, and providing consulting services from AstraZeneca,
